US FDA approves GSK's measles, mumps and rubella vaccine Priorix - Pharmaceutical Business Review
6/7/2022 12:00:00 AM2 years 11 months ago
by vbandhakavi
by vbandhakavi
The US FDA has approved the use of GSK’s Priorix to prevent measles, mumps and rubella (MMr) in children aged 12 months and older.
The US Food and Drug Administration (FDA) has approved the use of GSKs Priorix to prevent measles, mumps and rubella (MMR) in children aged 12 months and older. The approval will increase MMR vaccin… [+1817 chars]
full article...